Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$3.75 USD
-0.34 (-8.31%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.76 +0.01 (0.27%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
APDN 3.75 -0.34(-8.31%)
Will APDN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APDN
Allegion (ALLE) Q1 Earnings Surpass Estimates
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
ADT (ADT) Q2 Earnings and Revenues Miss Estimates
Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates
Other News for APDN
Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more
Applied DNA Sciences Unveils New Investor Engagement Material
Applied Dna Sciences, OptimizeRx, SCWorx among healthcare movers
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Applied DNA Sciences trading halted, news pending